Search Results - "ARRESE, J. E"

Refine Results
  1. 1

    Non-dermatophyte Dermatoses Mimicking Dermatophytoses in Humans by Libon, F., Nikkels-Tassoudji, N., Dezfoulian, B., Arrese, J. E., Nikkels, A. F.

    Published in Mycopathologia (1975) (01-02-2017)
    “…Human dermatophytic cutaneous infections usually present as single or multiple slowly progressing annular erythemato-squamous lesions with a tendency to…”
    Get full text
    Journal Article Web Resource
  2. 2

    Satellite lesions accompanying herpes zoster: a new prognostic sign for high-risk zoster by el Hayderi, L., Bontems, S., Nikkels-Tassoudji, N., Arrese, J.E., Seidel, L., Meex, C., Nikkels, A.F.

    Published in British journal of dermatology (1951) (01-06-2015)
    “…Summary Background The incidence, clinical relevance and pathogenesis of single, isolated, varicella‐like skin lesions occurring far beyond the primary herpes…”
    Get full text
    Journal Article Web Resource
  3. 3

    Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments by Piérard-Franchimont, C, Piérard, G E, Arrese, J E, De Doncker, P

    Published in Dermatology (Basel) (01-01-2001)
    “…Ketoconazole (KET) is active to control dandruff and seborrhoeic dermatitis. Objective assessments comparing the 1% and 2% shampoo formulations are scant. This…”
    Get more information
    Journal Article
  4. 4

    Clinicopathologic presentations of dermatomycoses in cancer patients by Quatresooz, P, Piérard-Franchimont, C, Arrese, JE, Piérard, GE

    “…Many of the skin fungal infections in cancer patients may look similar to those infections in non‐cancer patients. However, in some cases, they become more…”
    Get full text
    Journal Article Web Resource
  5. 5

    The boosted antifungal topical treatment (BATT) for onychomycosis by Pierard, G. E., Pierard-Franchimont, C., Arrese, J. E.

    Published in Medical Mycology (2000)
    “…Despite promising pharmacodynamic and pharmacokinetic profiles, modern antifungals exhibit limited efficacy in the treatment of onychomycoses. The clinical and…”
    Get full text
    Journal Article
  6. 6

    Present and potential diagnostic techniques in onychomycosis by Piérard, Gérald E., Arrese, Jorge E., De Doncker, Piet, Piérard-Franchimont, Claudine

    “…The problem of onychomycosis has been frequently addressed during recent years. To makethe diagnosis of onychomycosis dermatologists have relied on clinical…”
    Get full text
    Journal Article
  7. 7

    Ipilimumab induces simultaneous regression of melanocytic naevi and melanoma metastases by Libon, F., Arrese, J. E., Rorive, A., Nikkels, A. F.

    Published in Clinical and experimental dermatology (01-04-2013)
    “…Summary Ipilimumab blocks cytotoxic T‐lymphocyte‐associated antigen (CTLA)‐4, potentiating the antimelanoma T‐cell host response. Ipilimumab has been shown to…”
    Get full text
    Journal Article Web Resource
  8. 8

    Cutaneous mucormycosis by Flagothier, C., Arrese, J.E., Quatresooz, P., Piérard, G.E.

    Published in Journal de mycologie médicale (01-06-2006)
    “…Zygomycosis encompasses infections due to two distinct orders of fungi, Mucorales and Entomophthorales. With rare exceptions Entomophthorales are restricted to…”
    Get full text
    Journal Article Web Resource
  9. 9

    Effects of human growth hormone therapy on melanocytic naevi by Bourguignon, J P, Piérard, G E, Ernould, C, Heinrichs, C, Craen, M, Rochiccioli, P, Arrese, J E, Franchimont, C

    Published in The Lancet (British edition) (12-06-1993)
    “…Melanocytic naevi may grow more rapidly during human growth hormone (hGH) therapy. With standardised skin photographs, the growth rate of the naevi was…”
    Get more information
    Journal Article
  10. 10

    Antifungal activity of itraconazole and terbinafine in human stratum corneum: A comparative study by Piérard, G.E, Arrese, J.E, De Doncker, P

    “…Background: The evaluation of antifungal agents by in vitro and animal experiments cannot predict clinical efficacy with certainty. New models are needed to…”
    Get full text
    Journal Article
  11. 11

    Itraconazole by Piérard, G E, Arrese, J E, Piérard-Franchimont, C

    Published in Expert opinion on pharmacotherapy (01-01-2000)
    “…Itraconazole is a broad spectrum triazole antifungal agent. It has favourable pharmacodynamic and pharmacokinetic profiles and is available as both oral and…”
    Get more information
    Journal Article
  12. 12

    Euclidean and fractal computer-assisted corneofungimetry: a comparison of 2% ketoconazole and 1% terbinafine topical formulations by Arrese, J E, Fogouang, L, Piérard-Franchimont, C, Piérard, G E

    Published in Dermatology (Basel) (01-01-2002)
    “…The corneofungimetry bioassay was designed as a unique model predicting the efficacy of topical and oral antifungals in dermatomycoses. In this 2-step study…”
    Get more information
    Journal Article
  13. 13

    Epidemiology of onychomycoses assessed by histomycology in psoriatic patients by Piérard-Franchimont, C., Arrese, J.E., Hermanns-Lê, T., Piérard, G.E.

    Published in Journal de mycologie médicale (01-09-2006)
    “…Onychomycosis is a common condition in the adult population. It has been reported to be more prevalent in association with some specific diseases including…”
    Get full text
    Journal Article Web Resource
  14. 14

    Scytalidium dimidiatum melanonychia and scaly plantar skin in four patients from the Maghreb: imported disease or outbreak in a Belgian mosque? by Arrese, J E, Piérard-Franchimont, C, Piérard, G E

    Published in Dermatology (Basel) (01-01-2001)
    “…Scytalidium dimidiatum is a geophilic dematiaceous, non-dermatophyte mould that can become a pathogen for plants and humans particularly in tropical and…”
    Get more information
    Journal Article
  15. 15

    Treatment and prophylaxis of tinea infections by PIERARD, G. E, ARRESE, J. E, PIERARD-FRANCHIMONT, C

    Published in Drugs (New York, N.Y.) (01-08-1996)
    “…Superficial fungal infections affect millions of people throughout the world. Among them, tinea represents cutaneous infections by dermatophytes. Therapeutic…”
    Get full text
    Journal Article
  16. 16

    Familial Kufs' disease presenting as a progressive myoclonic epilepsy by SADZOT, B, REZNIK, M, ARRESE-ESTRADA, J. E, FRANCK, G

    Published in Journal of neurology (01-06-2000)
    “…Kufs' disease is the adult form of a group of disorders referred to as neuronal ceroid-lipofuscinosis or Batten's disease. We report here the clinical and…”
    Get full text
    Journal Article Web Resource
  17. 17

    Breast cancer metastatic to the eyelids by CLAESSENS, N, RAKIC, L, ARRESE, J. E, PIERARD, G. E

    Published in EJD. European journal of dermatology (01-08-2000)
    “…Metastases to the eyelids are rare. They may appear as diffuse swellings, nodules or ulcerations. Most often they correspond to the dissemination of a breast…”
    Get full text
    Journal Article
  18. 18

    Itraconazole corneofungimetry bioassay on Malassezia species by Piérard, G. E., Arrese, J. E., Piérard-Franchimont, C.

    Published in Mycoses (01-10-2004)
    “…Yeasts of the genus Malassezia are part of the normal skin biocenosis and are involved in a series of distinct skin disorders and specific dermatomycoses in…”
    Get full text
    Journal Article Web Resource
  19. 19

    Healing rate and bacterial necrotizing vasculitis in venous leg ulcers by Piérard-Franchimont, C, Paquet, P, Arrese, J E, Piérard, G E

    Published in Dermatology (Basel) (01-01-1997)
    “…Morbidity associated with venous leg ulcers is important in the elderly. The biological processes involved during attempts at healing are much more complex…”
    Get more information
    Journal Article
  20. 20

    The boosted oral antifungal treatment for onychomycosis beyond the regular itraconazole pulse dosing regimen by Piérard, G E, Piérard-Franchimont, C, Arrese, J E

    Published in Dermatology (Basel) (01-01-2000)
    “…Modern treatments for onychomycosis do not yield an ideal cure rate. The boosted oral antifungal treatment (BOAT) is introduced as a novel approach improving…”
    Get more information
    Journal Article